Texas Christian University Logo - TCU

Interleukin 2 (IL-2)

Can be measured in:

Interleukin 2 (IL-2) is also known as T-cell growth factor. IL-2 is a pleiotropic cytokine produced and released by activated T cells that plays a key role in regulating T-cell proliferation. This cytokine is also involved in the prevention of autoimmune conditions by promoting immature T cells to differentiate into T regulatory cells. IL-2 is used as a pharmaceutical drug in the treatment of certain cancers. Because levels of this cytokine are typically low in the blood of healthy people, an ultra-sensitive assay may be required to measure this cytokine in serum or plasma. This analyte is eligible for multiplexing.

You will be asked to indicate sample size once you have added all desired analytes to the cart.

Name: Interleukin 2 (IL-2)
Category: Health & Inflammation
Type of test: Blood + Saliva 

Interleukin-2 (IL-2), also known as T-cell growth factor, is a pleiotropic cytokine that, among other functions, regulates T-cell proliferation and differentiation. IL-2 is primarily produced by activate T helper and cytotoxic T cells; IL-2 receptors are express by lymphocytes. IL-2 signals are transduced through a variety of signaling pathways, such as JAK-STAT and MAPK/ERK pathways, which activate transcription factors, like NFkB.

IL-2 plays important roles in both immune defenses against infection, as well as protection against autoimmunity. These effects are mediated primarily through the effects of IL-2 on T cells. For example, in the thymus, IL-2 promotes differentiation of immature T cells into regulatory T cells. Regulatory T cells prevent autoimmunity by dampening excessive immune responses and promoting tolerance of self-antigens. Further, IL-2 promotes the production of memory T cells and is thus involved in facilitating adaptive immunity. In addition to T cells, IL-2 enhances NK cell responses and has been shown to activate NK cells in vitro. IL-2 also has clinical applications, such as in the treatment of certain cancers, including renal cell carcinoma and metastatic melanoma. 

IL-2 also influences the central nervous system. For example, IL-2 receptors interact with the cholinergic system. Through this pathway and others, IL-2 has been shown to attenuate neuroinflammation in murine models of traumatic brain injury.  IL-2 can be measured in both saliva and blood. The extent to which serum / plasma and salivary levels of this cytokine correlate is yet to be determined.

Araujo, D. M., Lapchak, P. A., & Collier, B. (1989). Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Research498, 257-266. https://pubmed.ncbi.nlm.nih.gov/2790482/

Gao, W., Li, F., Zhou, Z., Xu, X., Wu, Y., Zhou, S., ... & Zhang, J. (2017). IL-2/Anti-IL-2 complex attenuates inflammation and BBB disruption in mice subjected to traumatic brain injury. Frontiers in Neurology8, e281. https://www.frontiersin.org/articles/10.3389/fneur.2017.00281/full

Sim, G. C., & Radvanyi, L. (2014). The IL-2 cytokine family in cancer immunotherapy. Cytokine and Growth Factor Reviews25, 377-390. https://pubmed.ncbi.nlm.nih.gov/25200249/

Taniguchi, T., & Minami, Y. (1993). The IL-2IL-2 receptor system: a current overview. Cell73(1), 5-8. https://pubmed.ncbi.nlm.nih.gov/8462103/

Skip to content